Evidence map›Paper›PMID 32509360›Full record

ArticleCase reports in hematology2020

Myeloid Sarcomas Causing Unilateral Cranial Nerve Palsies in a Patient with Relapsed Acute Myeloblastic Leukemia.

A Mendez-Hernandez, X A Andrade, S Upadhyay, L M Parra-Rodriguez, E Caldeira, L H Paz, H Mann, M Zia, L Sumoza

Open access · goldAbstract readCase Reports
In one paragraph

Article in Case reports in hematology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 56% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 6 institutions in 1 country.

A Mendez-HernandezDepartment of Medicine, John H. Stroger Jr. Hospital of Cook County, Chicago, IL, USA.ORCID https://orcid.org/0000-0003-1701-329X
X A AndradeDepartment of Hematology and Oncology, Mayo Clinic, Rochester, MN, USA.
S UpadhyayDepartment of Medicine, John H. Stroger Jr. Hospital of Cook County, Chicago, IL, USA.
L M Parra-RodriguezDepartment of Medicine, John H. Stroger Jr. Hospital of Cook County, Chicago, IL, USA.
E CaldeiraDepartment of Medicine, Advocate Illinois Masonic Medical Center, Chicago, IL, USA.
L H PazDepartment of Cardiology, North Shore University Hospital, Evanston, IL, USA.
H MannDepartment of Hematology and Oncology, Tufts Medical Center, Boston, MA, USA.
M ZiaDepartment of Hematology and Oncology, John H., Stroger Jr., Hospital of Cook County, Chicago, IL, USA.
L SumozaDepartment of Hematology and Oncology, Alton Memorial Hospital, Alton, IL, USA.
John H. Stroger, Jr. Hospital of Cook County · USAdvocate Illinois Masonic Medical Center · USAlton Towers Resort · USMayo Clinic in Arizona · USNorth Shore University Hospital · USTufts Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Myeloid sarcomas (MS) are a rare manifestation of myeloid malignancies and can often be misdiagnosed, leading to a delay in treatment. The objective of this clinical case is to highlight the challenges of the clinical presentation and to emphasize the importance of this manifestation ensuring timely diagnosis and therapy. Here, we present a 43-year-old man who was diagnosed with acute myeloblastic leukemia (AML) after being evaluated for unintentional weight loss, subcutaneous nodules, thrombocytopenia, and anemia. The patient underwent chemotherapy with complete remission and presented 4 months later with dysphagia and cranial nerve palsies. Appropriate imaging and biopsy led to a diagnosis of myeloid sarcoma, and a decision was made to begin reinduction chemotherapy for AML achieving a second complete remission although his neurological deficits did not improve. Our case illustrates the protean presentation of myeloid sarcomas; clinicians should have a high suspicion for MS and remain vigilant when unexplained signs and symptoms arise in the background of a myeloid malignancy although challenges still remain when presentation is de novo. Advancements in understanding the pathophysiology of MS have been performed but remain not completely understood. High clinical suspicion, appropriate imaging, biopsy techniques, and expertise are paramount for timely diagnosis and treatment.

Identifiers

PMID32509360
PMCPMC7201833
OpenAlexW2999147794

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.